Production (Stage)
Genocea Biosciences, Inc.
GNCAQ
$0.00
$0.000.00%
OTC PK
03/31/2022 | 12/31/2021 | 09/30/2021 | 06/30/2021 | 03/31/2021 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -69.51% | -53.43% | -44.18% | 173.20% | 149.10% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 53.36% | 90.15% | -36.88% | -1.76% | 8.70% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -64.53% | -49.14% | -43.97% | 155.05% | 136.73% |
|
|||||
Total Current Assets | -64.53% | -49.14% | -43.97% | 155.05% | 136.73% |
Net Property, Plant & Equipment | -1.37% | -8.11% | -2.46% | -1.44% | -4.01% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -38.35% | -51.83% | -58.14% | -57.14% | -23.11% |
Total Assets | -53.79% | -43.18% | -38.87% | 90.99% | 85.74% |
|
|||||
Total Accounts Payable | -42.55% | -6.37% | 72.49% | 100.88% | 20.23% |
Total Accrued Expenses | 102.58% | 53.51% | 27.56% | 67.54% | 15.14% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 71.13% | -54.85% | -56.61% | -64.92% | -57.28% |
Total Finance Division Other Current Liabilities | 10.65% | -18.35% | -62.89% | 30.93% | 198.45% |
Total Other Current Liabilities | 10.65% | -18.35% | -62.89% | 30.93% | 198.45% |
Total Current Liabilities | 57.83% | -25.25% | -38.26% | -31.09% | -22.10% |
|
|||||
Total Current Liabilities | 57.83% | -25.25% | -38.26% | -31.09% | -22.10% |
Long-Term Debt | -61.47% | -- | -- | -- | 31.54% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -30.78% | -27.94% | -25.51% | -23.41% | -21.56% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -99.98% | -99.25% | 2,917.33% | 3,141.29% |
Total Liabilities | -67.87% | -67.72% | -68.50% | 125.77% | 155.37% |
|
|||||
Common Stock & APIC | 12.31% | 13.37% | 13.83% | 8.98% | 9.07% |
Retained Earnings | -9.62% | -8.86% | -9.70% | -10.09% | -12.46% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 602.89% | 201.44% | 87.23% | -44.72% | -85.69% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 602.89% | 201.44% | 87.23% | -44.72% | -85.69% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 602.89% | 201.44% | 87.23% | -49.55% | -86.46% |
|